KFDA set forth revaluation of 1,544 drugs next year.

Published: 1999-09-30 10:36:00

Updated: 1999-09-30 10:36:00

The KFDA announced that the drug revaluation works would be conducted for the total 1,544 products including 240 hormone and 250 remedies for anal use, and the detailed scope of revaluation drugs are as follows:

Hormones.

-Pituitary grand hormones (24 products)
-Salivary grand hormones ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK